Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBT Margin (2016 - 2025)

Mesa Laboratories' EBT Margin history spans 16 years, with the latest figure at 7.06% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 1059.0% to 7.06% in Q4 2025 year-over-year; TTM through Dec 2025 was 5.68%, a 11918.0% increase, with the full-year FY2025 number at 2.47%, up 12998.0% from a year prior.
  • EBT Margin hit 7.06% in Q4 2025 for Mesa Laboratories, up from 3.29% in the prior quarter.
  • Over the last five years, EBT Margin for MLAB hit a ceiling of 12.89% in Q1 2021 and a floor of 467.42% in Q1 2024.
  • Historically, EBT Margin has averaged 20.61% across 5 years, with a median of 3.41% in 2022.
  • Biggest five-year swings in EBT Margin: tumbled -46693bps in 2024 and later soared 46817bps in 2025.
  • Tracing MLAB's EBT Margin over 5 years: stood at 4.28% in 2021, then soared by 182bps to 3.53% in 2022, then increased by 3bps to 3.64% in 2023, then crashed by -197bps to 3.53% in 2024, then skyrocketed by 300bps to 7.06% in 2025.
  • Business Quant data shows EBT Margin for MLAB at 7.06% in Q4 2025, 3.29% in Q3 2025, and 11.78% in Q2 2025.